Status:
ACTIVE_NOT_RECRUITING
Nexus Evaluation Primary Trident II Uncemented Shell
Lead Sponsor:
NHS Lothian
Collaborating Sponsors:
University of Edinburgh
Conditions:
Arthritis of Hip
Hip Dysplasia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a prospective cohort study assessing the survival of a new acetabula component which is based on the original Trident acetabular system (cementless shell) which is used for Total Hip Arthropla...
Detailed Description
125 patients will be recruited at a single-centre as part of a, phase-4 post-market surveillance, prospective cohort study This is a 10-year study of the Trident II acetabular component as part of to...
Eligibility Criteria
Inclusion
- Patients undergoing planned primary total hip arthroplasty with standard implants, suitable for the use of the uncemented Trident® II acetabular component.
- Patients aged 18-75
- Patients willing and able to comply with the study protocol
- Patients that provide informed consent
Exclusion
- Patients not meeting study inclusion criteria
- Bone stock that is inadequate for support or fixation of the prosthesis
- Patients with a body mass index (kg/m2) \>40
- Procedures performed for pain relief in those with severely restricted mobility
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 25 2034
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT05366712
Start Date
June 1 2022
End Date
November 25 2034
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Lothian
Edinburgh, Lothian, United Kingdom, EH16 4SA